BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11086857)

  • 21. Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.
    Klonjkowski B; Klein D; Galea S; Gavard F; Monteil M; Duarte L; Fournier A; Sayon S; Górna K; Ertl R; Cordonnier N; Sonigo P; Eloit M; Richardson J
    Vaccine; 2009 Feb; 27(6):928-39. PubMed ID: 19070641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AIDS vaccines show promise in primates.
    Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258
    [No Abstract]   [Full Text] [Related]  

  • 23. AIDS vaccines: problems and prospects.
    Kirsten WH; Arthur LO
    Mod Pathol; 1993 May; 6(3):239-41. PubMed ID: 7688460
    [No Abstract]   [Full Text] [Related]  

  • 24. AIDS vaccine development.
    Lévy JP
    Science; 1998 May; 280(5365):806-7. PubMed ID: 9599149
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.
    Matano T; Kobayashi M; Igarashi H; Takeda A; Nakamura H; Kano M; Sugimoto C; Mori K; Iida A; Hirata T; Hasegawa M; Yuasa T; Miyazawa M; Takahashi Y; Yasunami M; Kimura A; O'Connor DH; Watkins DI; Nagai Y
    J Exp Med; 2004 Jun; 199(12):1709-18. PubMed ID: 15210746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1999: a time to re-evaluate AIDS vaccine strategies.
    Ruprecht RM; Hofmann-Lehmann R; Rasmussen RA; Vlasak J; Xu W
    J Hum Virol; 2000; 3(2):88-93. PubMed ID: 10850895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primate models of AIDS vaccine development.
    Lamb-Wharton RJ; Joag SV; Stephens EB; Narayan O
    AIDS; 1997; 11 Suppl A():S121-6. PubMed ID: 9451975
    [No Abstract]   [Full Text] [Related]  

  • 28. Introduction: Back to basics: mucosal immunity and novel HIV vaccine concepts.
    Broliden K; Haase AT; Ahuja SK; Shearer GM; Andersson J
    J Intern Med; 2009 Jan; 265(1):5-17. PubMed ID: 19093956
    [No Abstract]   [Full Text] [Related]  

  • 29. Naturally occurring animal models of the acquired immune deficiency syndrome (AIDS).
    Letvin NL; King NW
    Am J Physiol Imaging; 1991; 6(1):1-15. PubMed ID: 1645558
    [No Abstract]   [Full Text] [Related]  

  • 30. AIDS vaccines: back to 'plan A'.
    Check E
    Nature; 2003 Jun; 423(6943):912-4. PubMed ID: 12827164
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of the SIV model in AIDS vaccine research.
    Friedrich TC; Watkins DI
    IAVI Rep; 2005; 9(2):1, 6-8. PubMed ID: 16156073
    [No Abstract]   [Full Text] [Related]  

  • 32. Vaccination against the feline immunodeficiency virus: the road not taken.
    Lecollinet S; Richardson J
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):167-90. PubMed ID: 17706778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cold shower for AIDS vaccines.
    Nat Med; 2007 Dec; 13(12):1389-90. PubMed ID: 18064013
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV and SIV CTL escape: implications for vaccine design.
    Goulder PJ; Watkins DI
    Nat Rev Immunol; 2004 Aug; 4(8):630-40. PubMed ID: 15286729
    [No Abstract]   [Full Text] [Related]  

  • 35. AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: reevaluation of neutralizing antibody levels elicited by a protective and a nonprotective vaccine after removal of antisubstrate cell antibodies.
    Giannecchini S; Del Mauro D; Matteucci D; Bendinelli M
    J Virol; 2001 May; 75(9):4424-9. PubMed ID: 11287594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
    Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
    Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AIDS wins this round.
    Park A
    Time; 2007 Nov; 170(21):55. PubMed ID: 18074642
    [No Abstract]   [Full Text] [Related]  

  • 38. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
    Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
    J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons from the cat: development of vaccines against lentiviruses.
    Dunham SP
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):67-77. PubMed ID: 16678276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New hope for an AIDS vaccine.
    Robinson HL
    Nat Rev Immunol; 2002 Apr; 2(4):239-50. PubMed ID: 12001995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.